Cargando…
Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2
The ongoing severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) evolution has resulted in many variants, contributing to the striking drop in vaccine efficacy and necessitating the development of next-generation vaccines to tackle antigenic diversity. Herein we developed a multivalent Semli...
Autores principales: | Jawalagatti, Vijayakumar, Kirthika, Perumalraja, Hewawaduge, Chamith, Yang, Myeon-sik, Park, Ji-Young, Oh, Byungkwan, Lee, John Hwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810265/ https://www.ncbi.nlm.nih.gov/pubmed/35123065 http://dx.doi.org/10.1016/j.ymthe.2022.01.042 |
Ejemplares similares
-
A Simplified SARS-CoV-2 Mouse Model Demonstrates Protection by an Oral Replicon-Based mRNA Vaccine
por: Jawalagatti, Vijayakumar, et al.
Publicado: (2022) -
Highly feasible immunoprotective multicistronic SARS-CoV-2 vaccine candidate blending novel eukaryotic expression and Salmonella bactofection
por: Jawalagatti, Vijayakumar, et al.
Publicado: (2021) -
Oral mRNA Vaccines Against Infectious Diseases- A Bacterial Perspective [Invited]
por: Jawalagatti, Vijayakumar, et al.
Publicado: (2022) -
Targeting primary and metastatic tumor growth in an aggressive breast cancer by engineered tryptophan auxotrophic Salmonella Typhimurium
por: Jawalagatti, Vijayakumar, et al.
Publicado: (2022) -
Coordinated interaction between Lon protease and catalase-peroxidase regulates virulence and oxidative stress management during Salmonellosis
por: Kirthika, Perumalraja, et al.
Publicado: (2022)